Plasma immunoreactive endothelin concentration correlates with severity of coronary artery disease in patients with stable angina pectoris and normal ventricular function

Journal of the American College of Cardiology

Volumn 28, Issue 1, 1996, Pages 14-19

  Salomone, Oscar A ^a   Elliott, Perry M ^a   Calviño, Ramón ^a   Holt, David ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROMA; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THORAX PAIN;

EID: 0030198952     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00110-6     Document Type: Article

References (28)

1. 1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. 2. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takayu F, Yuzaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988;238:249-54.
3. 3. Lerman A, Edwards B, Hallett J, Heublein D, Sandberg S, Burnett J. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
4. 4. Lerman A, Mark WI, Chesebro JH, et al. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation 1993;88:2923-8.
5. 5. Dashwood MR, Sykes M, Muddle J, et al. Autoradiographic localization of [125 I] endothelin binding sites in human blood vessels and coronary tissue: functional correlates. J Cardiovasc Pharmacol 1991;17 Suppl 7:S458-62.
6. 6. Dashwood MR, Barker G, Muddle J, Yacoub M, Martin J. [125 I]Endothelin-1 binding to vasa vasorum and regions of neovascularization in human and porcine blood vessels: a possible role for endothelin in intimal hyperplasia and atherosclerosis. J Cardiovasc Pharmacol 1993;23 Suppl 8:S343-7.
7. 7. Miyauchi T, Yanagisawa M, Tomizawa T, et al. Increased plasma concentration of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989;2:53-4.
8. 8. Stewart D, Kubac G, Costello K. Increased plasma endothelin-1 in early hours of acute myocardial infarction. J Am Coll Cardiol 1991;18:38-43.
9. 9. Tomoda H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J 1993;125:667-72.
10. 10. Ray SG, McMurray JJ, Morton JJ, Dargie HJ. Circulating endothelin in acute ischaemic syndromes. Br Heart J 1992;67:383-6.
11. 11. Wieczorek I, Haynes WG, Webb D, Ludlans CA, Fox KAA. Raised plasma endothelin in unstable angina and non Q wave myocardial infarction: relation to cardiovascular outcome. Br Heart J 1994;72:436-41.
12. 12. Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. Circulation 1995;91:941-7.
13. 13. Montalescot G, Viossat I, Chabrier PE, et al. Endothelin-1 in patients with coronary heart disease undergoing cardiac catheterization. J Am Coll Cardiol 1994;24:1236-41.
14. 14. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease. Circulation 1975;51 Suppl V:V-5-40.
15. 15. Dodge HT, Sandler H, Ballew DW, Lord JD. The use of biplane angiocardiography for the measurement of left ventricular volume in man. Am Heart J 1960;60:762-76.
16. 16. Chen L, Chester MR, Redwood S, Huang J, Leatham E, Kaski JC. Angiographic stenosis progression and coronary events in patients with "stabilized" unstable angina. Circulation 1995;91:2319-24.
17. 17. Tsutamoto T, Wada A, Maeda Y, Adachi T, Kinoshita M. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. J Am Coll Cardiol 1994;23:1427-33.
18. 18. Dockier JE, Hanet C, Berbinschi A, et al. Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentration in conscious dogs. Circulation 1991;84:2476-84.
19. 19. Yashuda M, Kohno M, Tahara A, et al. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J 1990;119:801-6.
20. 20. Qui S, Theroux P, Mardi M, Solymoss BC. Plasma endothelin-1 levels in stable and unstable angina. Cardiology 1993;82:12-9.
21. 21. Chester MR, Chen L, Tousoulis D, Poloniecki J, Kaski JC. Differential progression of complex and smooth stenoses within the same coronary tree in men with stable coronary artery disease. J Am Coll Cardiol 1995;25:837-42.
22. 22. Arendt RM, Wilbert-Lampen U, Heuckle L, Shmoeckel M, Shuler K, Richter WO. Increased endothelin plasma concentrations in patients with coronary artery disease or hyperlipoproteinemia without coronary events. Res Exp Med (Berl) 1993;193:225-30.
23. 23. Saito Y, Nakao K, Mukoyama M, Imura H. Increased plasma endothelin level in patients with essential hypertension [letter]. N Engl J Med 1990;322: 205.
24. 24. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens 1991;4:303-8.
25. 25. Kaski JC, Elliott PM, Salomone OA, et al. Plasma endothelin-1 concentration in patients with angina and normal coronary arteriograms. Br Heart J. 1995;74:620-4.
26. 26. Cannon RO, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation 1992;85:883-92.
27. 27. Ge J, Erbel R, Gerber T, et al. Intravascular ultrasound imaging of angiographically normal coronary arteries: a prospective study in vivo. Br Heart J 1994;71:572-8.
28. 28. Wiedermann JG, Schwartz A, Apfelbaum M: Anatomic and physiologic heterogeneity in patients with syndrome X: an intravascular ultrasound study. J Am Coll Cardiol 1995;25:1310-5.